# Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

> **NCT03224000** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 90 (actual)

## Conditions studied

- Malignant Neoplasms of Lip Oral Cavity and Pharynx
- Oropharyngeal Cancer

## Interventions

- **PROCEDURE:** Modified Barium Swallow (MBS)
- **BEHAVIORAL:** Swallowing Questionnaire
- **BEHAVIORAL:** Symptom Questionnaire
- **PROCEDURE:** Video-Strobe Procedure
- **PROCEDURE:** MRI Guided Intensity Modulated Radiotherapy (IMRT) Planning
- **PROCEDURE:** Standard-of-Care Intensity Modulated Radiotherapy (IMRT) Planning
- **RADIATION:** Intensity Modulated Radiotherapy (IMRT)

## Key facts

- **NCT ID:** NCT03224000
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-17
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03224000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03224000, "Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03224000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*